Investment Firm Just Reiterated Its Rating For This Biotech Company

Investment Firm Just Reiterated Its Rating For This Biotech Company.

Annexon: A Game-Changer in the Biotech Industry? Needham Thinks So

In the always evolving world of biotechnology, there's a company that has caught the attention of investors and analysts alike: Annexon Inc. (NASDAQ: $ANNX). Recently, Needham, one of the leading investment banking and asset management firms, has reiterated its 'Buy' rating on the company…